 |
| |||
| pharmaceutical entity (For example, a biotechnology entity that has an agreement with a pharmaceutical entity to share equally in the development of a specific drug ... that the biotechnology entity is licensing its IP or selling its compound to the pharmaceutical entity and/or providing research and development ... Alexander Demidov) | |||
| subject of circulation of medicinal products (consultant.ru StarfleetAcademy) | |||
| Party to the circulation of medicinal products (usda.gov Olga_Tyn) | |||